Maris-Tech Further Expands into the Defense World – Launches Emerald Raw Video Recording Solution
Rehovot, Israel, Feb. 26, 2024 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK) (“Maris-Tech” or the “Company”), a B2B provider of […]
Codexis to Participate in TD Cowen 44th Annual Health Care Conference
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced […]
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on […]
BranchOut Food Significantly Expands Relationship with Nation’s Largest Warehouse Club with New Orders Adding ~$900,000 in Q3 of 2024
After exceptional sales in the California regions, BranchOut expands into 7 more states Several additional regions now reviewing BranchOut Food’s […]
Lincoln Educational Services Reports Results for Fourth Quarter and Full Year 2023
Conference Call Today at 10 a.m. ET PARSIPPANY, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC) […]
BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements
FLORHAM PARK, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage […]
Tempest to Present at the 44th Annual TD Cowen Healthcare Conference
BRISBANE, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted […]
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
ARLINGTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) — KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, […]
Mission Produce™ to Release Fiscal First Quarter 2024 Financial Results on Monday, March 11, 2024
OXNARD, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader […]
Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical […]
